Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
...
Next
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Post by
MirrorWorldMan
on Aug 31, 2022 1:09pm
Next Update needs to address;
1)Quell concerns over increased dilution. 2)Provide revenue guidance, estimate date of promised profitability. 3)Update on R + F product launch 16 months ago and explain hiatus in revenue over
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Aug 31, 2022 11:03am
Allergan strategic influences
https://news.allerganaesthetics.com/future-of-aesthetics Growth 10% annual for next decade. Looks like Sirona is an ideal partner.
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Aug 30, 2022 7:59pm
RE:RE:RE:RE:RE:New patent
If Abbvie picks this up too, global rights, or outright purchase, it could get very lucrative here.
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 30, 2022 7:51pm
RE:RE:RE:RE:RE:RE:New patent
If you read the full patent document that may even be buried in there. They are long, wordy and complex. :-))
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 30, 2022 6:30pm
RE:RE:RE:RE:New patent
Sounds like it may become a competitor to Botox??
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 30, 2022 5:16pm
RE:RE:RE:New patent
Excerpts from the patent documentation: Abstract The present invention relates to a glycopeptide of the following formula I: or a tautomer, a stereoisomer or a mixture of stereoisomers thereof in
...more
(1976)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 30, 2022 3:10pm
RE:RE:RE:JoJoe, Bets on upfront monies
Since the upfront from R+F was only $50,000, $1 million probably puts a smile on Howard's goofy face.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Aug 30, 2022 2:43pm
RE:RE:JoJoe, Bets on upfront monies
I would say the combination of all the milestones plus upfront payment would be that amount or higher but the upfront payment could in fact only a fraction of that. If it is on the low end, that would
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Aug 30, 2022 2:38pm
RE:RE:New patent
This may be part of IP protection- the anti-aging patents were filed at least a year or two ago..
(4)
•••
bazooka73
X
View Profile
View Bullboard History
Comment by
bazooka73
on Aug 30, 2022 2:33pm
RE:RE:RE:RE:JoJoe, Bets on upfront monies
how to turn p… into diamond
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 30, 2022 1:23pm
RE:New patent
They do not have the "patent" yet -- they just received the "Publication Number" so it is a ways off yet: Assignment abstract of title for Application 17627347
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Aug 30, 2022 1:21pm
RE:RE:JoJoe, Bets on upfront monies
Come on, Tickle. Put a dollar amount down and let's see where this ends up at. I'm tabulating any responses and then we can compare when we actually find out. I'm hoping the amount
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Aug 30, 2022 12:44pm
RE:RE:JoJoe, Bets on upfront monies
less than 10 mil is a joke after the big mouth words from h. V.
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Comment by
LakeOromocto
on Aug 30, 2022 12:24pm
RE:JoJoe, Bets on upfront monies
12 mil usf
Prev
...
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >